Follow this preprint

Cerebrospinal fluid CXCL13 identifies a subgroup of people living with HIV with prominent intrathecal synthesis, immune activation, and neurocognitive impairment regardless of effective antiretroviral therapy

Mattia Trunfio, Lorenzo Mighetto, Laura Napoli, Cristiana Atzori, Marco Nigra, Giulia Guastamacchia, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
doi: https://doi.org/10.1101/2022.12.13.22283427
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.12.13.22283427
History 
  • December 14, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Mattia Trunfio1,*,
  2. Lorenzo Mighetto2,
  3. Laura Napoli1,
  4. Cristiana Atzori3,
  5. Marco Nigra2,
  6. Giulia Guastamacchia3,
  7. Stefano Bonora1,
  8. Giovanni Di Perri1 and
  9. Andrea Calcagno1
  1. 1Infectious Diseases Unit, Department of Medical Sciences at Amedeo di Savoia Hospital, University of Torino, 10149 Torino, Italy
  2. 2Diagnostic Laboratory Unit, Maria Vittoria Hospital, ASL Città di Torino, 10144 Torino, Italy
  3. 3Unit of Neurology, Maria Vittoria Hospital, ASL Città di Torino, 10144 Torino, Italy
  1. ↵*Corresponding author:
    Mattia Trunfio, Infectious Diseases Unit, Department of Medical Sciences at Amedeo di Savoia Hospital, University of Torino, Torino, Italy. E-mail: mattia.trunfio{at}edu.unito.it; phone: +3901143938884.
Back to top
Posted December 14, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Cerebrospinal fluid CXCL13 identifies a subgroup of people living with HIV with prominent intrathecal synthesis, immune activation, and neurocognitive impairment regardless of effective antiretroviral therapy
Mattia Trunfio, Lorenzo Mighetto, Laura Napoli, Cristiana Atzori, Marco Nigra, Giulia Guastamacchia, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
medRxiv 2022.12.13.22283427; doi: https://doi.org/10.1101/2022.12.13.22283427
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.